John Savage

John Savage is a seasoned IT professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Sr Director of IT R&D at Crinetics Pharmaceuticals, John aligns systems and processes to facilitate NDA and HA inspections while developing a prioritized AI Playbook. Previously, John held the role of Sr. Director, Site Lead and R&D IT Business Partner at Bristol Myers Squibb, where a significant R&D systems strategy was created to support Turning Point Therapeutics' submission of Repotrectinib. Additional experience includes directing IT business solutions at Neurocrine Biosciences, overseeing IT support at Sorrento Therapeutics, and managing IT for both Hologic and Alere, with responsibilities spanning application deployment, validation, and IT service management. John holds a BA in International Finance from Loyola Marymount University and several technology certifications, including ITIL Foundations.